“RENAL AND HEPATIC IMPAIRMENT BROUGHT ON BY CISPLATIN WITHOUT COMPROMISING ANTICANCER EFFICACY”. (2024) Romanian Journal of Diabetes, Nutrition and Metabolic Diseases, 31(1), pp. 394–406. Available at: https://jrdiabet.ro/index.php/RJDNMD/article/view/307 (Accessed: 18 May 2024).